Evaluate the Efficacy and Safety of NYX-2925 in Subjects With Fibromyalgia
Clinical trial NCT03249103 · COMPLETED
Trial details
- NCT number
- NCT03249103
- Sponsor
- Aptinyx
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-14
- Primary completion
- 2019-04-18
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.